These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32445789)

  • 1. Is COVID-19-related Guillain-Barré syndrome different?
    Gupta A; Paliwal VK; Garg RK
    Brain Behav Immun; 2020 Jul; 87():177-178. PubMed ID: 32445789
    [No Abstract]   [Full Text] [Related]  

  • 2. Guillain-Barré syndrome following COVID-19: new infection, old complication?
    Padroni M; Mastrangelo V; Asioli GM; Pavolucci L; Abu-Rumeileh S; Piscaglia MG; Querzani P; Callegarini C; Foschi M
    J Neurol; 2020 Jul; 267(7):1877-1879. PubMed ID: 32333166
    [No Abstract]   [Full Text] [Related]  

  • 3. Guillain-Barré syndrome related to SARS-CoV-2 infection.
    Bigaut K; Mallaret M; Baloglu S; Nemoz B; Morand P; Baicry F; Godon A; Voulleminot P; Kremer L; Chanson JB; de Seze J
    Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32461235
    [No Abstract]   [Full Text] [Related]  

  • 4. Post SARS-CoV-2 Guillain-Barré syndrome.
    Arnaud S; Budowski C; Ng Wing Tin S; Degos B
    Clin Neurophysiol; 2020 Jul; 131(7):1652-1654. PubMed ID: 32422529
    [No Abstract]   [Full Text] [Related]  

  • 5. Guillain-Barré syndrome associated with COVID-19 infection: a case from the UK.
    Tiet MY; AlShaikh N
    BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32641309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guillain-Barré Syndrome Associated with SARS-CoV-2 infection].
    Esteban Molina A; Mata Martínez M; Sánchez Chueca P; Carrillo López A; Sancho Val I; Sanjuan-Villarreal TA
    Med Intensiva (Engl Ed); 2020 Nov; 44(8):513-514. PubMed ID: 32532531
    [No Abstract]   [Full Text] [Related]  

  • 7. Guillain-Barré Syndrome in a Patient With Minimal Symptoms of COVID-19 Infection.
    Oguz-Akarsu E; Ozpar R; Mirzayev H; Acet-Ozturk NA; Hakyemez B; Ediger D; Karli N;
    Muscle Nerve; 2020 Sep; 62(3):E54-E57. PubMed ID: 32497292
    [No Abstract]   [Full Text] [Related]  

  • 8. Guillain-Barré syndrome as a complication of SARS-CoV-2 infection.
    Coen M; Jeanson G; Culebras Almeida LA; Hübers A; Stierlin F; Najjar I; Ongaro M; Moulin K; Makrygianni M; Leemann B; Kronig I; Bertrand J; Reny JL; Schibler M; Serratrice J
    Brain Behav Immun; 2020 Jul; 87():111-112. PubMed ID: 32360440
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatal Guillain-Barre syndrome after infection with SARS-CoV-2.
    Marta-Enguita J; Rubio-Baines I; Gastón-Zubimendi I
    Neurologia (Engl Ed); 2020 May; 35(4):265-267. PubMed ID: 32364124
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease.
    Abrams RMC; Kim BD; Markantone DM; Reilly K; Paniz-Mondolfi AE; Gitman MR; Choo SY; Tse W; Robinson-Papp J
    J Neurovirol; 2020 Oct; 26(5):797-799. PubMed ID: 32720233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré-Strohl syndrome and COVID-19: Case report and literature review.
    Diez-Porras L; Vergés E; Gil F; Vidal MJ; Massons J; Arboix A
    Neuromuscul Disord; 2020 Oct; 30(10):859-861. PubMed ID: 32912716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2.
    Juliao Caamaño DS; Alonso Beato R
    J Clin Neurosci; 2020 Jul; 77():230-232. PubMed ID: 32410788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2-associated Guillain-Barré syndrome with dysautonomia.
    Su XW; Palka SV; Rao RR; Chen FS; Brackney CR; Cambi F
    Muscle Nerve; 2020 Aug; 62(2):E48-E49. PubMed ID: 32445201
    [No Abstract]   [Full Text] [Related]  

  • 15. [SARS-CoV-2, a new causal agent of Guillain-Barre syndrome].
    Redondo-Urda MJ; Rodríguez-Peguero FJ; Pérez-Gil O; Del Valle-Sánchez M; Carrera-Izquierdo M
    Rev Neurol; 2020 Oct; 71(7):275-276. PubMed ID: 32959360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome after covid-19 infection.
    García-Manzanedo S; López de la Oliva Calvo L; Ruiz Álvarez L
    Med Clin (Barc); 2020 Oct; 155(8):366. PubMed ID: 32718718
    [No Abstract]   [Full Text] [Related]  

  • 17. Relation between COVID-19 and Guillain-Barré syndrome in adults. Systematic review.
    Trujillo Gittermann LM; Valenzuela Feris SN; von Oetinger Giacoman A
    Neurologia (Engl Ed); 2020; 35(9):646-654. PubMed ID: 32896460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barré Syndrome Associated with SARS-CoV-2.
    Toscano G; Palmerini F; Ravaglia S; Ruiz L; Invernizzi P; Cuzzoni MG; Franciotta D; Baldanti F; Daturi R; Postorino P; Cavallini A; Micieli G
    N Engl J Med; 2020 Jun; 382(26):2574-2576. PubMed ID: 32302082
    [No Abstract]   [Full Text] [Related]  

  • 19. Guillain-Barré syndrome related to COVID-19 infection.
    Alberti P; Beretta S; Piatti M; Karantzoulis A; Piatti ML; Santoro P; Viganò M; Giovannelli G; Pirro F; Montisano DA; Appollonio I; Ferrarese C
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32350026
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19-Associated Bifacial Weakness with Paresthesia Subtype of Guillain-Barré Syndrome.
    Hutchins KL; Jansen JH; Comer AD; Scheer RV; Zahn GS; Capps AE; Weaver LM; Koontz NA
    AJNR Am J Neuroradiol; 2020 Sep; 41(9):1707-1711. PubMed ID: 32586958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.